Swiss Industrial Biocatalysis Consortium (SIBC)

Authors

  • Beat Wirz Pharmaceuticals, Therapeutic Modalities Process Research & Synthesis Basel, Biocatalysis F. Hoffmann-La Roche AG CH-4070 Basel;, Email: beat.wirz@roche.com
  • Matthias Kittelmann GDC/PSB/Bioreactions Novartis Pharma AG CH-4002 Basel
  • Hans-Peter Meyer Lonza AG CH-3930 Visp
  • Roland Wohlgemuth Research Specialties Sigma-Aldrich Industriestrasse 25 CH-9470 Buchs

DOI:

https://doi.org/10.2533/chimia.2010.780

Keywords:

Biocatalysis, Sibc, Swiss industrial biocatalysis consortium

Abstract

Taking up the common challenges in biocatalysis, a group of industrialists decided to react with a bottom-up solution, and created the Swiss Industrial Biocatalysis Consortium (SIBC). The Swiss Industrial Biocatalysis Consortium is a pre-competitive working group to better implement and utilize existing know-how and resources in biocatalysis, and to influence and shape the economic and educational political environment.Recent examples of activities are outlined.
CHIMIA Vol. 64 No. 11 (2010): Swiss Biotech

Downloads

Published

2010-11-26

How to Cite

[1]
B. Wirz, M. Kittelmann, H.-P. Meyer, R. Wohlgemuth, Chimia 2010, 64, 780, DOI: 10.2533/chimia.2010.780.

Issue

Vol. 64 No. 11 (2010): Swiss Biotech

Section

Scientific Articles

License

Copyright (c) 2010 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.